Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06882356 · ClinicalTrials.gov registry record · NA

The Glaucoma and Retinopathy Screening Study

A NA study of Glaucoma, sponsored by Massachusetts Eye and Ear Infirmary.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
5
Study locations

NCT06882356 is a NA study of Glaucoma that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 2,000 participants, above the 889-participant average among 92 other Glaucoma trials with a reported enrollment target (125% higher). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06882356, a NA study of Glaucoma, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
5
Study locations

Study Summary

The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset

Conditions Studied

Glaucoma

Interventions

  • DEVICE AI-based glaucoma screening
  • DEVICE IOP measurement
  • DEVICE Virtual Reality Visual Field Testing

Study Locations (5)

Massachusetts

  • Brigham and Women's Primary Care Associates of Longwood - Boston
  • MGH Chelsea HealthCare Center - Chelsea
  • NSPG Lynn - Lynn
  • NSPG Salem - Salem
  • NSPG Saugus - Saugus

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-07-16
Est. Completion 2030-09
Phase NA

Sponsor

Massachusetts Eye and Ear Infirmary

73 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06882356

The ClinicalTrials.gov registry entry for NCT06882356 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 889-participant average among 92 other Glaucoma trials with a reported enrollment target (125% higher). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 3 interventions - of which AI-based glaucoma screening is the first listed.

NCT06882356 reports 5 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06882356 about?

NCT06882356 is a clinical study titled "The Glaucoma and Retinopathy Screening Study". The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the ...

What is the current status of trial NCT06882356?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-07-16. Estimated completion is 2030-09.

What conditions does trial NCT06882356 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT06882356?

The interventions under investigation include: AI-based glaucoma screening (DEVICE), IOP measurement (DEVICE), Virtual Reality Visual Field Testing (DEVICE).

Who is sponsoring clinical trial NCT06882356?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06882356 being conducted?

This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.